Carboxylate derivatives of tributyltin (IV) complexes as anticancer and antileishmanial agents

Background Tributyltin (IV) compounds are promising candidates for drug development. In the current study, we evaluated in-vitro and in-silico profile of carboxylate derivatives of tributyltin (IV) complexes.